Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW May 16, 2022
Discovering potential emerging SARS-CoV-2 variants

Discovering potential emerging SARS-CoV-2 variants

From the Zhao, Gilbert, Geraghty and Jerome labs, a collaboration between Public Health Sciences, Vaccine and Infectious Disease, and the Clinical Research Divisions
Science Spotlight - April 18, 2022
Biostatisticians draft blueprints for COVID-19 vax trials

Biostatisticians draft blueprints for COVID-19 vax trials

Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Hutch News - February 18, 2021
Closer is better

Closer is better

From the Gilbert group, Vaccine and Infectious Disease Division
Science Spotlight - October 15, 2018
Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award

Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award

American Public Health Association recognizes Fred Hutch researcher for his contributions to health statistics biology
Hutch News - July 13, 2018
5 questions on new dengue vaccine analysis

5 questions on new dengue vaccine analysis

Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines
Hutch News - June 20, 2018
Predicting a durable immune response

Predicting a durable immune response

From HIV Vaccine Trails Network and Vaccine and Infectious Disease Division
Science Spotlight - March 20, 2017
Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success

Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success

Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
Hutch News - April 09, 2012
Last Modified, April 02, 2020